Kiyoka Kinugawa
Kiyoka Kinugawa is an expert in Geriatrics at Hôpital Charles-Foix (France). As of April 2026, ScienceLeadR ranks Kiyoka Kinugawa in the top 1% of experts worldwide for Hip Injuries. Kiyoka Kinugawa has authored 53 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 349 (community average: 125). How the SLR is computed.
LeadR Profile
Geriatrics
Subspecialties: Psychiatry - Biochemistry - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 53
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Sleep disorders in the elderly and their management. PMID 41963174 — psychosomatic medicine, sleep, synucleinopathies, aged, therapeutics, neurology, restless legs syndrome, psychiatry | Encephale | 2026 | 0 |
| New cross-disciplinary sleep medicine residency in France: Results after five years. PMID 40187984 — psychosomatic medicine, sleep, psychopharmacology, research, neurology, psychiatry | Encephale | 2025 | 0 |
| Étude auprès des étudiants en médecine sur la formation spécialisée transversale en médecine du sommeil en France OpenAlex W4404109085 — sleep, data collection, sleep medicine specialty | Médecine du Sommeil | 2024 | 0 |
| Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey. PMID 38608749 — alzheimer disease, biochemistry, dementia, biomarkers, peptide hydrolases, therapeutics, serine proteases, kallikreins | Biochimie | 2024 | 1 |
| Prise en charge thérapeutique par Pression Positive Continue du Syndrome d’apnées du sommeil modéré à sévère des patients âgés OpenAlex W4392261308 — sleep, receptors, proteinase-activated, therapeutics, hand strength, continuous positive airway pressure | Médecine du sommeil/Medecine du sommeil | 2024 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| High definition Surface Electromyography Markers for the Diagnosis and Monitoring of Sarcopenia NCT06963359 — exercise, muscles, electromyography, quadriceps muscle, muscle strength, diagnosis, beds, sarcopenia | N/A | Recruiting | 2025 |
| High definition Surface Electromyography Markers for the Diagnosis of Sarcopenia NCT04987814 — exercise, muscles, electromyography, quadriceps muscle, muscle strength, diagnosis, beds, sarcopenia | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map